معرفی
José de León, MD, is a Professor in the Department of Psychiatry at the University of Kentucky, with joint appointments in the College of Medicine and College of Pharmacy. A native of Bilbao, Spain, he trained at the University of Navarre before specializing in clinical psychopharmacology in Philadelphia (1987-1991). He joined the University of Kentucky in 1996 as Associate Professor, promoted to Professor in 2006, and serves as Medical Director for the Mental Health Research Center at Eastern State Hospital since 1996.
- Education: University of Navarre (MD), Clinical Psychopharmacology Fellowships in Philadelphia
- Awards: None explicitly listed
His research focuses on pharmacogenomics and psychopharmacology, particularly the interplay between genetic polymorphisms (e.g., CYP2D6, CYP3A4) and antipsychotic drug response. He pioneered studies on the global schizophrenia-smoking association, valproate-induced drug metabolism, and ultrarapid metabolizer phenotypes in psychiatric patients. Recent work (2024) explores Alzheimer's disease pathogenesis through mitochondrial dysfunction and apolipoprotein E mechanisms.
Key trends in his 15 most recent publications (2024-2005) span:
- Neurodegenerative Diseases: Mitochondria, Apolipoprotein E in Alzheimer's
- Psychiatric Pharmacology: Clozapine titration, risperidone adverse reactions, bipolar drug interactions
- Clinical Medicine: Pulmonary fibrosis, Baker's cyst, chronic wound management
As a co-author on interdisciplinary studies (e.g., Adenosine in cardiovascular systems, integrated pediatrics-behavioral health), his work bridges psychiatry with broader medical disciplines. He has contributed to 330+ PubMed publications as of 2018, with >700 citations for his schizophrenia-smoking meta-analysis.
.jpg)
